Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Proven Techniques for Reining In Supply Chain Costs

Proven Techniques for Reining In Supply Chain Costs Healthcare delivery in the United States is experiencing a period of extreme flux and uncertainty that is combining to escalate costs. It is compounded by a healthcare supply chain which is vast, complex and plagued with inefficiencies. Supply costs can account for 25-30% of a hospital’s operating…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want MarketScale to feature Healthcare?

Book a 15-minute demo and we'll map your Healthcare expertise to the content buyers are searching for.

Book a demo

Proven Techniques for Reining In Supply Chain Costs

Healthcare delivery in the United States is experiencing a period of extreme flux and uncertainty that is combining to escalate costs. It is compounded by a healthcare supply chain which is vast, complex and plagued with inefficiencies. Supply costs can account for 25-30% of a hospital’s operating budget. Supplies relate directly to the patient experience, making it difficult to always settle for the least expensive option. Consequently, hospitals are continually faced with the challenge of decreasing supply chain costs without compromising patient care.

Supply Chain and Physician Preference Items

The balance of cost and function may be most true with Physician Preference Items (PPI) that can account for up to 60% of supply spend. As individual physicians typically select those specific tools with which they are most comfortable, PPI products can be extremely varied across the hospital. This variance, coupled with the high cost of PPI products, makes it difficult for hospital administrators to reduce spend across their organization. In order to keep supply spend in check, healthcare administrators must work collaboratively with physicians and their established preferences to address the financial bottom line and efforts to reduce costs while also improving efficiencies. It’s a collective approach among all stakeholders to balance cost, quality and outcomes.

One opportunity to significantly reduce supply chain inefficiencies and costs is through product standardization. By eliminating the number of similar products, hospitals are able to negotiate more aggressively with vendors to achieve higher value. When it comes to PPI, consideration should be made to determine which items are “preference” driven versus clinically necessary.

Standardizing physician preference items requires involving physicians in the process and educating them with clinical and financial data of clinical utilization patterns, patient outcomes, and product costs and value. While a complex and involved process, the savings extracted from a strategic focus on PPI is well worth the time and investment. TPC is a proven leader in assessing PPI opportunities, collaborating with physicians, and developing successful PPI programs that reduce supply spend without compromising clinical quality or patient care.

TPC Focus on Supply Chain and Physician Preference Items

The TPC model enables hospitals to aggregate their volume to wield increased purchasing power. By drawing upon the combined expertise of Members, TPC gives physicians, nurses, pharmacists and other clinical specialists a method to evaluate products and assess their financial value, as well as their impact on the quality of care. We have found a niche in custom contracting for high-value, complex PPI categories, such as spine and cardiology. By initiating conversations with physicians early in the process we can more effectively evaluate and analyze differences across products and vendors.

TPC collaborates with Members to create a better understanding of the market landscape and drive better decision making. Together, we level-set technology across multiple manufacturers in complex categories and drive standardization in pricing. TPC works with Clinical Value Analysis Teams (CVATs) and Physician Sub-Committees (PSCs) comprised of clinical leaders from each Member facility. These groups offer functionally equivalent, cost-effective solutions to promote a culture of clinical excellence and financial stewardship for all TPC Members. Functional equivalence is determined by objective review of the product using specific, predetermined criteria, and not based on clinical or operational preference. The members of CVATs and PSCs are of vital importance as they serve as clinical advisors, initiative champions and provide clinical input into product decisions.

Through TPC’s custom contracts, Members have achieved significant savings in multiple product categories including, $3.45 million in Cardiac Rhythm Management, $3.5 million in Spinal Implants, and $1.6 million in Interventional Cardiology. As healthcare systems across the country are seeking ways to generate cost savings in the complex category of supply chain, the TPC collaborative model has proven results in reducing supply chain expenses, especially in the challenging area of PPI.

Stronger Together. Superior Results. To learn more about TPC services for supply chain savings, visit http://www.tpc1.com/supply-chain/ today!

Read more at tpc1.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The healthcare industry faces significant consequences when delayed decision-making occurs. Prompt and efficient action is crucial to prevent adverse impacts on patient care and operational efficiency. Addressing this issue requires a commitment to more agile and informed decision processes.

  • 01Delayed decision-making in healthcare can lead to negative impacts on patient care and operational efficiency.
  • 02Healthcare organizations are encouraged to adopt agile decision-making processes to improve effectiveness.
  • 03Implementing informed and prompt decision-making strategies can mitigate the risks of inefficiencies and poor patient outcomes.

Aug 16, 2026

Why Childcare is a CEO Problem - Nicole Riehl, EPIC

Childcare has become a critical issue that CEOs must address to ensure workplace productivity and employee satisfaction. Addressing childcare challenges can lead to improved employee retention and a more diverse workforce. Companies need to implement supportive policies that accommodate working parents.

  • 01Childcare is a significant concern for CEOs aiming to maintain workforce productivity.
  • 02Implementing supportive childcare policies can enhance employee retention.
  • 03Accommodating working parents is essential for fostering a diverse workforce.

Aug 16, 2026

AI scribes and startup pipelines are reshaping how health systems and tech investors evaluate AI in 2026

AI scribes and startup pipelines are reshaping how health systems and tech investors evaluate AI in 2026

AI scribes and startup incubators are transforming the evaluation process of AI technologies in healthcare and tech investments. The focus is on balancing innovation with ethical considerations like patient consent and strategic startup growth. The evolving landscape requires health systems and investors to adapt to new evaluation criteria.

  • 01AI scribes are raising ethical concerns about patient consent in healthcare.
  • 02Startup incubators like Y Combinator are focusing on AI-first strategies.
  • 03Health systems and tech investors must adapt to new criteria for evaluating AI technologies.

Aug 16, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512